ONCOLOGY

September 21, 2021

PARP Inhibitor Maintenance Therapy Expanding in Recurrent Ovarian Cancer

September 21, 2021

One-Half of Low-Risk PC Patients Transition From Active Surveillance to Active Treatment

September 21, 2021

Research Reveals How PARP Inhibitors Work

September 17, 2021

Focus on Anemia in Managing Lower-Risk Myelodysplastic Syndromes

September 1, 2021

Some BP Drugs Show Association With Colorectal Cancer Survival

August 18, 2021

Androgen-Receptor Inhibitors for Prostate Cancer Okay for Men Aged 80 Years and Older

July 21, 2021

Contemporary Developments in MET-Selective Kinase Inhibitors in Advanced Non–Small-Cell Lung Cancer

July 14, 2021

Is There a Link Between Antibiotic Use, Colorectal Cancer in Younger Adults?

June 16, 2021

Antibiotic Use Linked to Reduced Effectiveness for Common NSCLC Therapy

June 11, 2021

Breast Cancer: Not Just a Female Disease

June 9, 2021

Pandemic Had Dramatic Effect on Care for Prostate-Cancer Patients

June 9, 2021

Here’s Why Breast Cancer Patients Aren’t Adhering to Endocrine Therapy

April 16, 2021

Cytomegalovirus Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients

September 2021

September 2021

In This Issue Digital Magazine Archives Subscription

Related CE

$6.97 Per CE Exam or $59 for 12 Lessons

The Pharmacist's Role in Testicular Cancer Treatment

View More CE

Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.